Virtual Reality After Breast Reconstruction Surgery

The primary objective of this study is to estimate the effect of utilizing VR on reducing
opioid use in study participants undergoing mastectomy with implant-based reconstruction
compared to the control group. Investigators will follow patients throughout the course of
their hospitalization and monitor outcomes including pain levels, medication requests, and
satisfaction.

Eligible participants will receive a VR headset and instructed to use the VR every time they
feel pain and before asking for a pain medication. They can take pain medications, if they
choose to do so. At their post-op visit, study participants will be interviewed and asked
questions regarding their experience with VR.

Pain level and medication use will be compared with similar individuals who undergo the same
procedure but are not provided with a VR headset.

Inclusion Criteria:

- Age ≥ 18 years

- Women who plan to undergo mastectomy and implant-based reconstruction

- Written informed consent obtained from subject and ability for subject to comply with
the requirements of the study.

- Able to read and comprehend English

Exclusion Criteria:

- Current diagnosis of epilepsy, dementia, or other neurologic disease that may prevent
use of VR headset and software

- Sensitivity to flashing light

- Diagnosis of motion sickness

- Pregnancy or a medical condition where the study participant is prone to frequent
nausea or dizziness

- Current or recent (less than 6 months) use of opioids

- Individuals with psychiatric disorders, including those with delirium or other
disorders that may involve hallucinations or psychosis